BACKGROUND: ICF syndrome (standing for Immunodeficiency, Centromere instability and Facial anomalies syndrome) is a very rare autosomal recessive immune disorder caused by mutations of the gene de novo DNA-methyltransferase 3B (DNMT3B). However, in the literature similar clinical cases without such mutations are reported, as well. RESULTS: We report on a family in which the unrelated spouses had two female siblings sharing similar phenotypic features resembling ICF-syndrome, i.e. congenital abnormalities, immunodeficiency, developmental delay and high level of chromosomal instability, including high frequency of centromeric/pericentromeric rearrangements and breaks, chromosomal fragments despiralization or pulverization. However, mutations in DNMT3B could not be detected. CONCLUSION: The discovery of a new so-called 'chromatin disorder' is suggested. Clinical, molecular genetic and cytogenetic characteristics are reported and compared to other 'chromatin disorders'.
BACKGROUND:ICF syndrome (standing for Immunodeficiency, Centromere instability and Facial anomalies syndrome) is a very rare autosomal recessive immune disorder caused by mutations of the gene de novo DNA-methyltransferase 3B (DNMT3B). However, in the literature similar clinical cases without such mutations are reported, as well. RESULTS: We report on a family in which the unrelated spouses had two female siblings sharing similar phenotypic features resembling ICF-syndrome, i.e. congenital abnormalities, immunodeficiency, developmental delay and high level of chromosomal instability, including high frequency of centromeric/pericentromeric rearrangements and breaks, chromosomal fragments despiralization or pulverization. However, mutations in DNMT3B could not be detected. CONCLUSION: The discovery of a new so-called 'chromatin disorder' is suggested. Clinical, molecular genetic and cytogenetic characteristics are reported and compared to other 'chromatin disorders'.
Authors: G L Xu; T H Bestor; D Bourc'his; C L Hsieh; N Tommerup; M Bugge; M Hulten; X Qu; J J Russo; E Viegas-Péquignot Journal: Nature Date: 1999-11-11 Impact factor: 49.962
Authors: Barbara Kloeckener-Gruissem; David R Betts; Andreas Zankl; Wolfgang Berger; Tayfun Güngör Journal: Am J Med Genet A Date: 2005-07-01 Impact factor: 2.802
Authors: Y L Jiang; M Rigolet; D Bourc'his; F Nigon; I Bokesoy; J P Fryns; M Hultén; P Jonveaux; P Maraschio; A Mégarbané; A Moncla; E Viegas-Péquignot Journal: Hum Mutat Date: 2005-01 Impact factor: 4.878
Authors: Alma Kuechler; Susann Neubauer; Gerhard G Grabenbauer; Uwe Claussen; Thomas Liehr; Rolf Sauer; Thomas G Wendt Journal: Strahlenther Onkol Date: 2002-04 Impact factor: 3.621
Authors: R S Hansen; R Stöger; C Wijmenga; A M Stanek; T K Canfield; P Luo; M R Matarazzo; M D'Esposito; R Feil; G Gimelli; C M Weemaes; C D Laird; S M Gartler Journal: Hum Mol Genet Date: 2000-11-01 Impact factor: 6.150